Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKinsey
Boehringer Ingelheim
Colorcon
Queensland Health
Mallinckrodt
Julphar
Daiichi Sankyo
McKesson
Johnson and Johnson

Generated: May 21, 2018

DrugPatentWatch Database Preview

Mylan Labs Ltd Company Profile

« Back to Dashboard

What is the competitive landscape for MYLAN LABS LTD, and what generic and branded alternatives to MYLAN LABS LTD drugs are available?

MYLAN LABS LTD has one hundred and sixty-two approved drugs.

There are seven tentative approvals on MYLAN LABS LTD drugs.

Summary for Mylan Labs Ltd
US Patents:0
Tradenames:105
Ingredients:96
NDAs:162

Drugs and US Patents for Mylan Labs Ltd

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Mylan Labs Ltd PAMIDRONATE DISODIUM pamidronate disodium INJECTABLE;INJECTION 078520-002 Oct 31, 2008 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd HEPARIN SODIUM heparin sodium INJECTABLE;INJECTION 203852-001 Nov 30, 2017 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd CYTARABINE cytarabine INJECTABLE;INJECTION 200916-001 Dec 13, 2011 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Mylan Labs Ltd PIPERACILLIN AND TAZOBACTAM piperacillin sodium; tazobactam sodium INJECTABLE;INJECTION 065458-001 Aug 15, 2014 AP RX No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Federal Trade Commission
Express Scripts
Julphar
Dow
Argus Health
Fuji
Harvard Business School
McKinsey
Cipla

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.